Heartburn Meds Could Up Risk Of Fractures: FDA
The U.S. Food and Drug Administration is requiring new warnings on AstraZeneca's Prilosec, Pfizer Inc.'s Protonix, Takeda Pharmaceutical Co. Ltd.'s Prevacid and other acid reflux and ulcer drugs to reflect a...To view the full article, register now.
Already a subscriber? Click here to view full article